000 | 01625 a2200433 4500 | ||
---|---|---|---|
005 | 20250516070822.0 | ||
264 | 0 | _c20120504 | |
008 | 201205s 0 0 eng d | ||
022 | _a1521-0103 | ||
024 | 7 |
_a10.1124/jpet.111.186957 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSharina, Iraida | |
245 | 0 | 0 |
_aCobinamides are novel coactivators of nitric oxide receptor that target soluble guanylyl cyclase catalytic domain. _h[electronic resource] |
260 |
_bThe Journal of pharmacology and experimental therapeutics _cMar 2012 |
||
300 |
_a723-32 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCatalytic Domain |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCobamides _xpharmacology |
650 | 0 | 4 |
_aGuanylate Cyclase _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNitric Oxide _xphysiology |
650 | 0 | 4 |
_aPyrazoles _xpharmacology |
650 | 0 | 4 |
_aPyridines _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xdrug effects |
650 | 0 | 4 | _aSoluble Guanylyl Cyclase |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 |
_aVitamin B 12 _xpharmacology |
700 | 1 | _aSobolevsky, Michael | |
700 | 1 | _aDoursout, Marie-Francoise | |
700 | 1 | _aGryko, Dorota | |
700 | 1 | _aMartin, Emil | |
773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 340 _gno. 3 _gp. 723-32 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1124/jpet.111.186957 _zAvailable from publisher's website |
999 |
_c21393218 _d21393218 |